Macleods Pharmaceuticals Ltd — Valsartan Exporter Profile
Indian Pharmaceutical Exporter · #2 for Valsartan · $27.9M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #2 Indian exporter of Valsartan with $27.9M in export value and 558 verified shipments. Macleods Pharmaceuticals Ltd holds a 14.2% market share in Valsartan exports across 32 countries.
Macleods Pharmaceuticals Ltd — Valsartan Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Valsartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $7.8M | 254 | 47.6% |
| GERMANY | $1.5M | 43 | 9.4% |
| MALTA | $1.1M | 37 | 6.9% |
| GREECE | $845.1K | 28 | 5.2% |
| UNITED ARAB EMIRATES | $597.6K | 22 | 3.7% |
| POLAND | $550.5K | 32 | 3.4% |
| SOUTH AFRICA | $536.6K | 36 | 3.3% |
| CHILE | $428.7K | 22 | 2.6% |
| FRANCE | $390.2K | 57 | 2.4% |
| HONDURAS | $326.3K | 24 | 2.0% |
Macleods Pharmaceuticals Ltd exports Valsartan to 36 countries. The largest destination is UNITED STATES accounting for 47.6% of Macleods Pharmaceuticals Ltd's Valsartan shipments, followed by GERMANY (9.4%) and MALTA (6.9%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Valsartan from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MACLEODS PHARMA USA INC | UNITED STATES | $2.7M | 91 |
| MACLEODS PHARMA USA,INC | UNITED STATES | $1.9M | 59 |
| MACLEODS PHARMA USA ,INC | UNITED STATES | $1.2M | 48 |
| HEUMANN PHARMA GMBH & CO. | MALTA | $993.3K | 31 |
| MACLEODS PHARMA USA.INC | UNITED STATES | $968.5K | 30 |
| HEUMANN PHARMA GMBH CO | MALTA | $662.8K | 22 |
| DEMO SA PHARMACEUTICAL INDUSTRY | GREECE | $642.4K | 23 |
| MACLEODS PHARMA USA, INC.,. | UNITED STATES | $522.6K | 14 |
| GULF PHARMACEUTICAL INDUSTRIES | UNITED ARAB EMIRATES | $432.7K | 13 |
| NEXTPHARMA LOGISTICS GMBH | GERMANY | $431.9K | 11 |
Macleods Pharmaceuticals Ltd supplies Valsartan to 93 buyers globally. The largest buyer is MACLEODS PHARMA USA INC (UNITED STATES), followed by MACLEODS PHARMA USA,INC (UNITED STATES) and MACLEODS PHARMA USA ,INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Valsartan Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $113.6M worth of Valsartan through 6,098 shipments from 259 suppliers to 119 countries, serving 663 buyers globally. Macleods Pharmaceuticals Ltd contributes $27.9M to this total, accounting for 14.2% of India's Valsartan exports. Macleods Pharmaceuticals Ltd ships Valsartan to 36 countries through 93 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Valsartan Exports?
Macleods Pharmaceuticals Ltd's average Valsartan shipment value is $50.0K per consignment, based on 558 shipments totaling $27.9M. The largest destination is UNITED STATES (47.6% of Macleods Pharmaceuticals Ltd's Valsartan exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Valsartan Exporters?
Macleods Pharmaceuticals Ltd ranks #2 among 259 Indian Valsartan exporters with a 14.2% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($28.9M), MACLEODS PHARMACEUTICALS LTD ($27.9M), ALEMBIC PHARMACEUTICALS LIMITED ($10.5M). Macleods Pharmaceuticals Ltd processed 558 shipments to 32 destination countries.
What Valsartan Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VALSARTAN 320MG AND HCTZ 25MG TABLETS BN | $432.7K | 11 |
| VALSARTAN 320MG AND HCTZ 12.5MG TABLETS- | $314.3K | 10 |
| VALSARTAN 320MG AND HCTZ 25MG TABLETS-ND | $303.2K | 8 |
| LOVA PLUS (VALSARTAN 160MG AND HYDROCHLO | $218.5K | 6 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES VALSARTAN TABLETS USP 160 mg | $204.9K | 9 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (320 MG/ 25 MG) | $204.1K | 10 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (160 mg/ 12.5 mg) | $178.1K | 5 |
| AMLODIPINE AND VALSARTAN HYDROCHLOROTHIAZIDE TABLETS 5/160MG(COVADIR 5 /160MG)(3X 10S TABS) | $175.7K | 9 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (320 mg/ 25 mg) | $150.0K | 3 |
| VALSARTAN 160MG AND HCTZ 25MG TABLETS-ND | $148.9K | 4 |
Macleods Pharmaceuticals Ltd exports 514 distinct Valsartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VALSARTAN 320MG AND HCTZ 25MG TABLETS BN with 11 shipments worth $432.7K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Valsartan to Key Markets
What Macleods Pharmaceuticals Ltd must comply with to export Valsartan to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Valsartan Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $28.9M | 578 | 14 | $50.0K |
| 2 | MACLEODS PHARMACEUTICALS LTD ★ | $27.9M | 558 | 32 | $50.0K |
| 4 | ALEMBIC PHARMACEUTICALS LIMITED | $10.5M | 270 | 6 | $38.8K |
| 5 | DR.REDDY'S LABORATORIES LTD | $8.2M | 163 | 5 | $50.0K |
Macleods Pharmaceuticals Ltd ranks #2 among 259 Indian Valsartan exporters. Average shipment value of $50.0K compared to the market average of $438.5K. The closest competitors by value are MYLAN LABORATORIES LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Valsartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 946 | 15.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 707 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 627 | 10.3% |
| DELHI AIR | 516 | 8.5% |
| NHAVA SHEVA SEA (INNSA1) | 445 | 7.3% |
| JNPT/ NHAVA SHEVA SEA | 323 | 5.3% |
| JNPT | 213 | 3.5% |
| MUNDRA SEA | 176 | 2.9% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Valsartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Valsartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 764 individual customs records matching Macleods Pharmaceuticals Ltd exporting Valsartan, covering 514 formulations to 36 countries via 93 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 663+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Valsartan Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Valsartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Valsartan Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Valsartan. For current shipment-level data, contact TransData Nexus.